Tab Mirabegron 50 mg, Alfuzocin 10mg Tab,Tab Flupenthixol 05 mg and Malitracen 10 mg,Megestrol 160mg
Indian Army · Pharmaceuticals · open
Key facts
- Tender value: ₹1.9L
- Published: 28 Sep 2026
- Closing date: 13 Oct 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of various pharmaceutical products including Mirabegron, Alfuzocin, Flupenthixol, Malitracen, Megestrol, Carvedilol, Sofosbuvir, Velpatasvir, and other medicines and medical supplies. The procurement is for the Indian Army under the Ministry of Defence, Department of Military Affairs, with a total quantity of 32143 units. The bid validity is 180 days from the end date, with evaluation based on item-wise criteria. No EMD or ePBG required. Purchase preference for MSEs and startups is applicable. The estimated bid value is approximately 189225.85.
Eligibility & requirements
- Past performance: 30%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Supporting documents for relaxation, Contract and delivery certificates
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (4)
- Mirabegron 50 mg — Qty: 600 tablet
- Alfuzocin 10 mg — Qty: 180 tablet
- Flupenthixol 05 mg and Malitracen 10 mg
- Megestrol 160 mg
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Supply of automotive spare parts and components for Indian Army — Pharmaceuticals · Manipur
- Procurement of Medicines — Pharmaceuticals · Odisha · ₹75K
- Tab Cintapride 1mg,Tacrlolimus 0point 5mg Cap,carbamazepine cr 300mg tab,Cyclosporine A micro emuls — Pharmaceuticals · Telangana